Cartesian Therapeutics
RNAC
#7523
Rank
ยฃ0.22 B
Marketcap
ยฃ8.80
Share price
11.28%
Change (1 day)
-15.29%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -ยฃ60.09 Million

According to Cartesian Therapeutics's latest financial reports the company's current earnings are ยฃ38.91 Million. , an increase over its 2023 earnings that were of -ยฃ0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 -ยฃ60.36 Million-67.3%
2023 -ยฃ0.19 Billion-724%
2022 ยฃ29.57 M-649.67%
2021 -ยฃ5.39 Million-89.78%
2020 -ยฃ52.68 Million25.06%
2019 -ยฃ42.12 Million-15.68%
2018 -ยฃ49.96 Million-0.43%
2017 -ยฃ50.17 Million83.41%
2016 -ยฃ27.36 Million44.3%
2015 -ยฃ18.96 Million